Release date: 2016-03-15 In kidney transplant surgery, the most troublesome thing is to find a suitable donor. Due to the existence of immune rejection, in order to reduce the risk of organ rejection after surgery, it is best to find donors with very similar biological characteristics, which means that many kidney transplant donors are derived from relatives. Now a new technology allows patients to adapt to any donor kidney, which will greatly improve the cure rate of kidney patients. The new technology was published in the latest issue of the Journal of New England Medicine and was reported by The New York Times. Experts say the foundation is revolutionary and will dramatically reduce the amount of time patients wait for donors. In particular, this technique can alter a patient's immune system and reduce their level of response to heterogeneous organs. The specific molecular mechanisms are currently unclear, but newer antibodies appear to be less "repulsive" to the foreign organs that are transplanted. This process is called "desensitization" and has been practiced on a small scale before, but the recently reported article details the effect of this therapy. Based on data from more than 2,000 patients in 22 clinical trials, 76.5% of desensitized patients survived healthy for 8 years after transplantation of exogenous kidneys, which is better than control patients (ie, no relevant treatment, some kidney transplantation) Some, still waiting for the list, 62.9% of the survival rate of 8 years or more should be significantly improved. It takes a certain amount of time before the therapy is actually applied: first, the therapy is not officially approved, and the cost of this method is also very expensive ($30,000). Currently, one-third of patients who need a kidney transplant cannot find a suitable match, and 100,000 patients in the US are on the waiting list. This therapy seems to be the only option for this group of patients. "You don't have to wait for a perfectly fit living donor organ, you just need a living donor of any type," says Dr. Dorgy Segev, a researcher at Johns Hopkins University. Segev also believes that this technology can be used in other living organ transplants, such as the liver, lungs and so on. Source: Bio Valley Vitamins are a type of trace organic substances that humans and animals must obtain from food in order to maintain normal physiological functions. In terms of physiological functions, vitamins are neither a raw material for tissues nor a substance for supplying energy, but they are an indispensable substance for the body. It has many types and different chemical structures. Most of them are the components of the coenzyme (or prosthetic group) of certain enzymes. They are the indispensable compounds for maintaining the normal growth (growth, health, reproduction and production function) of the body. It plays a catalytic role in the body to promote the synthesis and degradation of major nutrients (proteins, fats, carbohydrates, etc.), thereby controlling metabolism. Vitamins are essentially low-molecular organic compounds. They cannot be synthesized in the body, or the amount synthesized is difficult to meet the needs of the body, so they must be supplied from the outside. The daily requirement of vitamins is very small (usually measured in milligrams or micrograms). They are neither a raw material for body tissues nor a substance for energy supply in the body. However, they do not regulate material metabolism, promote growth and development, and maintain physiological functions. Vitamin K2 MK-7, Vitamin C, Vitamin E, Vitamin K2, Vitamin H, Vitamin D3 Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com